Search results

Records found: 4  
Your query: Author Sysno/Doc.kind = "^sllk_un_auth 0019732 xcla^"

  1. 1.Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial

    Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial  / J. Ocvirk ... [et al.] .  Onkológia. - ISSN 1336-8176 . - Roč. 6, č. 1 (2011), s. 56  
    C 3069
    article

    article

  2. 2.Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)

    Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)  / A. Tomova ... [et al.] .  Onkológia. - ISSN 1336-8176 . - Roč. 6, č. 1 (2011), s. 56  
    C 3069
    article

    article

  3. 3.Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

    Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses  / Brodowicz T., Spanik S. ... [et al.] .  Onkológia. - ISSN 1336-8176 . - Roč. 10, č. 6 (2015), s. 402-403  
    C 3069
    article

    article

  4. 4.Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

    Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses  / Brodowicz, T. - Špánik, S. ... [et al.] .  Onkológia. - ISSN 1336-8176 . - Roč. 9, č. 6 (2014), s. 404-405  
    C 3069
    article

    article



  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all